Incidence, Risk Factors, and Mortality From Hospital-Acquired Infections at a Hospital in Mauritius
- PMID: 34976541
- PMCID: PMC8713534
- DOI: 10.7759/cureus.19962
Incidence, Risk Factors, and Mortality From Hospital-Acquired Infections at a Hospital in Mauritius
Abstract
Introduction Hospital-acquired infections can be associated with an increase in morbidity, length of stay, and cost. Data on this topic are very limited in Mauritius. This study seeks to identify (a) the most prevalent hospital-acquired infection locally, (b) the risk factors for acquiring nosocomial infections, and (c) the mortality rate linked to such infections. Methods This is an observational study that was conducted at a 600-bed hospital in Mauritius by going through the folders of 109 patients who were admitted in different wards. Cox regression was used to carry out the survival analysis. Results Over the past 25 years, the incidence of hospital-acquired infections has increased by two to three times in Mauritius to reach a value of 18 per 100 admitted patients. The most commonly identified nosocomial infection was ventilator-associated pneumonia. The presence of foreign devices increased the risk of acquiring nosocomial infections. The mortality rate from such infections was almost four times higher compared to the mortality rate from patients who did not suffer from these infections; however, after adjustment for potential confounders, this was not statistically significant. The incidence of ventilator-associated pneumonia and central line-associated bloodstream infections was high at 46 per 1,000 ventilator-days and 25 per 1,000 central line days, respectively. Conclusion Infection prevention and control measures should be implemented to curtail the rise of hospital-acquired infections in Mauritius. Such measures should include the use of bundles of care. In addition, periodic surveillance of nosocomial infections needs to be encouraged.
Keywords: central line-associated bloodstream infections; hospital-acquired infections; nosocomial; surgical site infections; ventilator-associated pneumonia.
Copyright © 2021, Nuckchady et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Impact on morbidity, mortality, and length of stay of hospital-acquired infections by resistant microorganisms. Barrasa-Villar JI, Aibar-Remón C, Prieto-Andrés P, Mareca-Doñate R, Moliner-Lahoz J. Clin Infect Dis. 2017;65:644–652. - PubMed
-
- Estimation of extra length of stay attributable to hospital-acquired infections in adult ICUs using a time-dependent multistate model. Ohannessian R, Gustin MP, Bénet T, et al. Crit Care Med. 2018;46:1093–1098. - PubMed
-
- Prevalence of infections and use of antibiotics among hospitalized patients in Mauritius. A nationwide survey for the planning of a national infection control programme. Jepsen OB, Jensen LP, Zimakoff J, et al. J Hosp Infect. 1993;25:271–278. - PubMed
-
- The prevalence of multi-drug resistant organisms and their outcomes in an ICU in Mauritius: an observational study. Nuckchady DC, Boolaky SH. Asian J Med Health. 2020;21:71–78.
-
- Bloodstream Infection Event (Central Line-Associated Bloodstream Infection and Non-central Line Associated Bloodstream Infection) [ Jul; 2021 ];https://www.cdc.gov/nhsn/pdfs/pscmanual/4psc_clabscurrent.pdf 2021
LinkOut - more resources
Full Text Sources
Miscellaneous